Real-World Characterization of Women with Diagnosed Endometriosis Initiating Therapy with Elagolix Using a US Claims Database

Real-World Characterization of Women with Diagnosed Endometriosis Initiating Therapy with Elagolix Using a US Claims Database

Eric S Surrey,1 Ahmed M Soliman,2 Beverly Johns,2 Jamie B Vora,3 Hugh S Taylor,4 Sanjay K Agarwal5 1Colorado Center for Reproductive Medicine, Lone Tree, CO, USA; 2Health Economics and Outcomes Research, AbbVie Inc, North Chicago, IL, USA; 3Healthcare Solutions, AbbVie Inc, North Chicago, IL, USA; 4...

Full description

Bibliographic Details
Main Authors:	Surrey ES, Soliman AM, Johns B, Vora JB, Taylor HS, Agarwal SK
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-08-01
Series:	ClinicoEconomics and Outcomes Research
Subjects:	gonadotropin-releasing hormone antagonist women’s health clinical characteristics demographics
Online Access:	https://www.dovepress.com/real-world-characterization-of-women-with-diagnosed-endometriosis-init-peer-reviewed-article-CEOR

Similar Items

Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients
by: Mauricio S. Abrao, et al.
Published: (2021-06-01)

Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results
by: Yutaka Osuga, et al.
Published: (2021-06-01)

Comparison of gonadotropin-releasing hormone agonist with GnRH antagonist in polycystic ovary syndrome patients undergoing in vitro fertilization cycle: Retrospective analysis from a tertiary center and review of literature
by: Neeta Singh, et al.
Published: (2014-01-01)

Elagolix in the treatment of endometriosis: impact beyond pain symptoms
by: David F. Archer, et al.
Published: (2020-11-01)

Impact of gonadotropin-releasing hormone antagonist addition on pregnancy rates in gonadotropin-stimulated intrauterine insemination cycles
by: Shikha Jain, et al.
Published: (2016-01-01)

A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
by: Jumpei Asakawa, et al.
Published: (2018-07-01)

Effect of Endometrium Thickness on Clinical Outcomes in Luteal Phase Short-Acting GnRH-a Long Protocol and GnRH-Ant Protocol
by: Jie Zhang, et al.
Published: (2021-05-01)

An Overview on the Protocols used in the Management of Infertility
by: Kundan V Ingale, et al.
Published: (2019-02-01)

Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study
by: Batool Hosein Rashidi, et al.
Published: (2019-03-01)

Endometriosis-Related Pain Reduction During Bleeding and Nonbleeding Days in Women Treated with Elagolix
by: Agarwal SK, et al.
Published: (2021-02-01)

ENDOMETRIOSIS AND FERTILITY. KEY MOMENT OF TREATMENT
by: S. A. Gasparyan, et al.
Published: (2016-06-01)

Supplementation with human menopausal gonadotropin in the gonadotropin-releasing hormone antagonist cycles of women with high AMH: Pregnancy outcomes and serial hormone levels
by: Liang-Hsuan Chen, et al.
Published: (2021-07-01)

Comparison of two regimens of gonadotropin-releasing hormone antagonists in clomiphene-gonadotropin induced controlled ovulation and intrauterine insemination cycles: Randomized controlled study
by: Sajja Devendra Siva Karthik, et al.
Published: (2018-01-01)

Repeat dose of gonadotropin-releasing hormone agonist trigger in polycystic ovarian syndrome undergoing In Vitro fertilization cycles provides a better cycle outcome - a proof-of-concept study
by: Krishna Deepika, et al.
Published: (2017-01-01)

DEGARELIX ROLE AND PLACE IN THE COMBINED TREATMENT OF PATIENTS WITH PROSTATE CANCER IN COMBINATION WITH CONCURRENT RADIOTHERAPY
by: A. Y. Pavlov, et al.
Published: (2016-02-01)

Efficacy of luteal estrogen administration and an early follicular Gonadotropin-releasing hormone antagonist priming protocol in poor responders undergoing fertilization
by: Hwajeong Lee, et al.
Published: (2018-01-01)

The use of gonadotropin-releasing hormone antagonist in women undergoing intrauterine insemination
by: M Yousef Elsemary, et al.
Published: (2019-01-01)

Cumulative live birth rates between GnRH-agonist long and GnRH-antagonist protocol in one ART cycle when all embryos transferred: real-word data of 18,853 women from China
by: Jingwei Yang, et al.
Published: (2021-08-01)

Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol
by: Behnaz Khani Rabati, et al.
Published: (2012-01-01)

Morning basal luteinizing hormone, a good screening tool for diagnosing central precocious puberty
by: Dong-Min Lee, et al.
Published: (2019-03-01)

Expression of genes for Kisspeptin (KISS1), Neurokinin B (TAC3), Prodynorphin (PDYN), and gonadotropin inhibitory hormone (RFRP) across natural puberty in ewes
by: Qun Li, et al.
Published: (2020-03-01)

Gonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: A Randomized control trial
by: Deepika Krishna, et al.
Published: (2016-01-01)

PARTICULAR FEATURES OF OVARIAN CYSTS AND ENDOMETRIOSIS TREATMENT
by: I. S. Sidorova, et al.
Published: (2016-09-01)

Gonadotropin-Releasing Hormone and Its Role in the Enteric Nervous System
by: Bodil Ohlsson, et al.
Published: (2017-06-01)

The role of the GLU2.53(90) residue in gonadotropin-releasing hormone receptor expression and function
by: Manilall, Ashmeetha
Published: (2017)

Is there a Need for Luteinizing Hormone (LH) Estimation in Patients Undergoing Ovarian Stimulation with Gonadotropin-Releasing Hormone (GnRH) Antagonists and Recombinant Follicle-Stimulating Hormone (rFSH)?
by: Amar Ramachandran, et al.
Published: (2014-01-01)

Importance of bone assessment and prevention of osteoporotic fracture in patients with prostate cancer in the gonadotropic hormone analogues use
by: Bruno Lopes Cançado, et al.

Usefulness of combined androgen blockade therapy with gonadotropin-releasing hormone antagonist for bone metastatic prostate cancer with pretreatment prostate-specific antigen level ≥ 50 ng/mL
by: Takeshi Kashiwabara, et al.
Published: (2018-05-01)

Comparison of Dydrogesterone and GnRH Antagonists for Prevention of Premature LH Surge in IVF/ICSI Cycles: A Randomized Controlled Trial
by: Batool Hossein Rashidi, et al.
Published: (2020-07-01)

Single random measurement of urinary gonadotropin concentration for screening and monitoring girls with central precocious puberty
by: Se Young Lee, et al.
Published: (2021-09-01)

Fixed versus flexible antagonist protocol in women with predicted high ovarian response except PCOS: a randomized controlled trial
by: Xiu Luo, et al.
Published: (2021-05-01)

Body mass index and basal androstenedione are independent risk factors for miscarriage in polycystic ovary syndrome
by: Wan Yang, et al.
Published: (2018-11-01)

Comparison of Vaginal Gel and Intramuscular Progesterone for In vitro Fertilization and Embryo Transfer with Gonadotropin-Releasing Hormone Antagonist Protocol
by: Hong-Bin Chi, et al.
Published: (2018-01-01)

Effects of Luteinizing Hormone Supplementation on Ovarian Response and Assisted Reproductive Technology Outcomes in Antagonist In vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: A Meta-analysis
by: Lei Chen, et al.
Published: (2019-01-01)

Empty follicle syndrome: Successful pregnancy following dual trigger
by: K Deepika, et al.
Published: (2015-01-01)

Do basal luteinizing hormone and luteinizing hormone/follicle-stimulating hormone ratio have significance in prognosticating the outcome of In vitro fertilization cycles in polycystic ovary syndrome?
by: Neeta Singh, et al.
Published: (2021-01-01)

Progress and Challenges in the Search for the Mechanisms of Pulsatile Gonadotropin-Releasing Hormone Secretion
by: Stephanie Constantin
Published: (2017-07-01)

TUMORAL AND NON TUMORAL PITUITARY LESIONS AND REPRODUCTIVE SYSTEM
by: I. A. Ilovayskaya
Published: (2012-05-01)

Central and direct regulation of testicular activity by gonadotropin-inhibitory hormone and its receptor
by: Takayoshi eUbuka, et al.
Published: (2014-01-01)

Intrinsic and Regulated Gonadotropin-Releasing Hormone Receptor Gene Transcription in Mammalian Pituitary Gonadotrophs
by: Marija M. Janjic, et al.
Published: (2017-09-01)